Form4insider filings, from the source

SEC Form 4 · accession 0001127602-18-009725

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Lonnel Coats
Officer — President and CEO · Director
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2018M10,836—A53,821D
Common StockF1Feb 28, 2018M8,390—A62,211D
Common StockF1Feb 28, 2018M5,362—A67,573D
Common StockFeb 28, 2018F9,494$8.53D58,079D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F3—Feb 28, 2018M10,836D——Common Stock10,83610,835D
Restricted Stock UnitsF1,F4—Feb 28, 2018M8,390D——Common Stock8,39016,780D
Restricted Stock UnitsF1,F5—Feb 28, 2018M5,362D——Common Stock5,36216,088D

Explanation of responses